Bioethics, Licensing and Pharmaceuticals

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Bioethics

Licensing

Pharmaceuticals

Deliberate Dysentery

Codon

JANUARY 21, 2024

We wouldn't do a challenge trial for Ebola, because the disease is extremely severe, and there are currently no licensed treatments or vaccines. People are hesitant to do this because it's not a particularly flashy disease to research, nor is this population the focus of major pharmaceutical companies. So you have to do a field study.

Vaccine

Vaccine Trials Disease Treatment

BetterLife’s Recent Acquisition: Taking LSD from Experimental to a Major Therapeutic Application

The Pharma Data

DECEMBER 14, 2020

Authors of “ An ethical exploration of barriers to research on controlled drugs ” in the American Journal of Bioethics have been quoted stating, “the classification of drugs as Schedule I amounts to an unsurmountable barrier to research.” About BetterLife Pharma Inc. BetterLife Pharma Inc.

Bioethics

Bioethics Clinical Research Regulations Clinical Trials

Drug Discovery Digest

Deliberate Dysentery

BetterLife’s Recent Acquisition: Taking LSD from Experimental to a Major Therapeutic Application

Stay Connected